Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Cardiology
Trial Title   EDUCATE: Endeavor Drug eluting stenting: Understanding Care, Antiplatelet agents and Thrombotic Events
Description of Research   The purpose of this study is to collect additional safety information on the Endeavor stent, which has already been approved by the Food and Drug Administration (FDA).
Also, the purpose of this study is to collect information about how two different time periods of antiplatelet therapy (two blood thinning medicines taken by mouth in pill form to prevent blood clots) following a stent procedure keep you free from death, heart attack, stroke, bleeding, or blood clots.
Study Number   HSR-10-1108
Inclusion/Notes   Your doctor will have explained to you that you have a problem with narrowing in one or more of your coronary arteries (blood vessels which supply blood to the muscle of your heart).
Principal Investigator   James Bengtson, MD
Contact Name   Nora Marchelletta, RN
Phone   (734) 712-7244
A Member of Trinity Health
© 2014 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456